Occudo Quantitative Strategies LP Annexon, Inc. Transaction History

Occudo Quantitative Strategies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.1 - $6.37 $209,353 - $635,038	99,692 New	99,692 $350,000
Q3 2022 Nov 14, 2022	SELL	$3.75 - $6.63 $139,361 - $246,390	-37,163 Reduced 72.45%	14,132 $87,000
Q2 2022 Aug 15, 2022	SELL	$2.11 - $4.06 $51,699 - $99,478	-24,502 Reduced 32.33%	51,295 $193,000
Q1 2022 May 16, 2022	BUY	$2.73 - $11.94 $206,925 - $905,016	75,797 New	75,797 $207,000

156

101M

3.73M

1.3M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $335M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.